Financial Shenanigans

Financial Shenanigans

Forensic risk is Elevated: Daqo does not look like a fraud story, but the trough has real accounting pressure in inventory, receivables, and non-GAAP framing. The top concern is sell-through: Q1 2026 production was 43,402 MT, sales were only 4,482 MT, and gross loss reached $139.4M. The clean offset is the balance sheet, with $1.94B of FY2025 cash and no staged financial debt.

The Forensic Verdict

Breeding Ground

Governance amplifies, but does not dominate, the accounting risk: the founder family and Daqo Group links create related-party oversight needs, while the audit committee has credible financial expertise.

Earnings Quality

Reported earnings are ugly rather than cosmetically clean, which lowers fraud suspicion but raises asset-mark risk.

Receivables rose sharply in FY2025 from a low base while revenue declined, a yellow flag for collection timing. The bigger earnings-quality issue is inventory marking: Q1 2026 gross margin was negative 521.5% after inventory provisions.

Cash Flow Quality

Cash flow is not overstated by leverage, but free cash flow remains hostage to capex and working capital.

Operating cash flow was positive in FY2025 despite a GAAP loss, but FCF stayed negative because capex was $173M. The next quality test is whether inventory converts to cash without discounting or another impairment.

Metric Hygiene

Management's non-GAAP measures are reconciled, but they can make the trough look cleaner than the GAAP economics.

What to Underwrite Next

Track Q2 sales volume, inventory provisions, receivable collections, and ASP versus total production cost. A downgrade would come from another quarter where production materially exceeds sales and impairment continues. An upgrade would come from volume normalization with stable DSO and no further inventory write-downs. Accounting risk is a valuation haircut and position-sizing limiter, not a thesis breaker by itself.